The brand new workflow shall allow routine meals testing laboratories to display.

This improved self-confidence in the total results produced from every injection will reduce the need for reinjections, and combined with the simplicity of the info processing workflow, thereby raises throughput for tests laboratories. ‘The primary advantage of this workflow is the improved confidence and dependability in the outcomes that it provides to food assessment labs,’ stated Vincent Paez, Sr. Director, Food & Environmental Markets, AB SCIEX. ‘Our initial results have tested that labs can decrease the dangers of reporting a false negative or a false positive result when applying this workflow in place of traditional workflows, such as regular MRM quantitation using ion ratios.’ Related StoriesStudy factors to potential treatment for thrombotic thrombocytopenic purpuraNew endoscopic program differentiates between malignant and benign tumors in gastrointestinal tractNew data analysis platform reveals major flaw in GC-MS processVisitors to the FERA/JIFSAN conference can view demonstrations of the brand new food testing software program on-board AB SCIEX'from June 9-11 s Mobile Lab, along with Abdominal SCIEX's sector leading, high-performance mass spectrometry systems and solutions for food monitoring, safety and surveillance.Kaiser Health News, an editorially independent news service, is an application of the Kaiser Family members Foundation, a nonpartisan healthcare policy research organization unaffiliated with Kaiser Permanente.

Aeterna Zentaris reports final results on clinical activity of perifosine for metastatic colorectal cancer Aeterna Zentaris Inc. , a late-stage drug development company specialized in oncology and endocrine therapy, today reported benefits on the clinical activity of perifosine , the business’s novel, potentially first-in-class, oral anticancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, in combination with capecitabine ) as cure for advanced, metastatic colorectal cancer.